|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Biogen (NASDAQ: BIIB) through any online brokerage.
The latest price target for Biogen (NASDAQ: BIIB) was reported by Cowen & Co. on October 21, 2021. The analyst firm set a price target for 375.00 expecting BIIB to rise to within 12 months (a possible 41.62% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Biogen (NASDAQ: BIIB) is $264.8 last updated Fri Oct 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Biogen.
Biogen’s $Q3 earnings are confirmed for after-market on $October 20, 2021.
There is no upcoming split for Biogen.
Biogen is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.